Inverse VIX Short-Term Futures ETNs due March 22, 2045
Limited financial coverage for VYLD.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This investment product is engineered to reflect the daily performance of the S&P500 VIX Short-Term Futures Points-Change Inverse Daily Index. The benchmark itself measures the day-to-day value changes resulting from maintaining a continuously updated short position in VIX futures contracts, which are traded on the Cboe Futures Exchange. Consequently, these notes are intended for investors who anticipate the value of this particular inverse index to rise during their ownership period, thereby generating a positive return.
- IPO
- 2025
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on VYLD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $30.63
- 52W Low
- $25.00
- 50D MA
- $29.76
- 200D MA
- $28.28
- Beta
- 0.62
- RSI (14)
- 64
- Avg Volume
- 1.60K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
JPMorgan posted another record quarter and full year, with strong fee and markets momentum, stable deposits, and a 2025 outlook that points to lower but still solid NII and higher expenses.· January 15, 2025
- Q4 net income was $14 billion, EPS was $4.81, and revenue was $43.7 billion, up 10% year over year.
- Full-year 2024 excluding significant items: net income of $54 billion, EPS of $18.22, revenue of $173 billion, and ROTCE of 20%.
- Management guided to 2025 NII ex-markets of about $90 billion and firm-wide NII of about $94 billion, with card growth slowing from 2024’s pace and deposit growth expected more visibly in 2H25.
- 2025 expenses are expected to be about $95 billion, reflecting continued spending on tech, branches, bankers, marketing, and other growth initiatives.
- Capital remained strong at a 15.7% CET1 ratio, and management said excess capital should stop growing, implying more buybacks if no near-term deployment appears.
The firm reported Q4 2024 net income of $14 billion, EPS of $4.81, revenue of $43.7 billion, and ROTCE of 21%. Revenue was up $3.8 billion, or 10% year over year. Expenses were $22.8 billion, down 7% year over year, and credit costs were $2.6 billion. For full-year 2024, excluding significant items, JPMorgan reported net income of $54 billion, EPS of $18.22, revenue of $173 billion, and ROTCE of 20%. Looking ahead, management guided to 2025 NII ex-markets of approximately $90 billion and firm-wide NII of approximately $94 billion. They expect 2025 expenses of about $95 billion and said 2025 card net charge-off rate should be in line with prior guidance of approximately 3.6%.
Jamie Dimon emphasized franchise strength, calling 2024 another year of record revenue and net income, but he also stressed that the firm is preparing for a range of scenarios given “tension in the risks and uncertainties in the environment” and what he sees as optimism embedded in asset prices. He was upbeat on the business, but cautious on the macro, saying JPMorgan is focused on being ready rather than complacent. He also said the company is not seeing broad-based loan growth acceleration yet despite improved business sentiment, and highlighted unemployment as the main credit driver, with stagflation as the worst-case vulnerability.
Jeremy Barnum walked through broad-based strength in the quarter: CCB revenue of $18.4 billion, CIB revenue of $17.6 billion, AWM revenue of $5.8 billion, and CET1 at 15.7%, up 40 bps sequentially. He noted full-year record net inflows in AWM of $234 billion and said the firm bought back $4 billion of stock in the quarter. On 2025, he guided to NII ex-markets of about $90 billion, total NII of about $94 billion, and expenses of about $95 billion, while saying the firm has enough excess capital and does not want it to keep growing, so buybacks are the likely pressure valve if deployment does not materialize.
Analysts focused heavily on capital and buybacks, asking how high JPMorgan would let excess capital build and whether special dividends or other tools could be used; management said they see enough excess capital already and want to arrest further growth, but refused to guide specific repurchases. They also pressed on regulation and the G-SIB/stress capital buffer math; Barnum said the firm is managing to current rules, expects to remain comfortably in the 5% G-SIB bucket based on seasonality, and wants a more coherent, less bureaucratic regulatory framework. On growth and credit, questions centered on loan demand, QT, and vulnerability to rates and tariffs; management said loan growth has not yet meaningfully improved, the main credit risk is unemployment, and QT could wind down around mid-year based on current consensus.
The quarter showed broad operating strength: record-like revenue and earnings, strong markets and banking fees, record long-term net inflows in AWM, and healthy card growth and client activity in CCB. Management remained confident in the franchise, said deposits have stabilized, and sees potential for stronger deposit growth in 2H25 and some loan growth pickup if deal activity and business confidence translate into real demand.
NII is expected to decline in 2025 versus 2024, with management saying the normalization thesis is still in place but less pronounced than earlier expected. Costs are also set to rise to about $95 billion, and management acknowledged ongoing regulatory uncertainty, capital rule complexity, and the risk that excess capital will keep building unless deployment opportunities improve.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 0.0%
- Shares Outstanding
- 96.41K
- Float Shares
- 0
Buy/sell ratio 0.57. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 25, 25 | Petno Douglas B | other | 45,373.798 |
| Mar 25, 25 | Petno Douglas B | other | 25,091.798 |
| Mar 25, 25 | Petno Douglas B | other | 45,373.798 |
| Mar 25, 25 | Pinto Daniel E | other | 17,826 |
| Mar 25, 25 | Pinto Daniel E | other | 19,524 |
| Mar 25, 25 | Pinto Daniel E | other | 20,904 |
| Mar 25, 25 | Pinto Daniel E | other | 22,688 |
| Mar 25, 25 | Pinto Daniel E | other | 59,169 |
| Mar 25, 25 | Pinto Daniel E | other | 23,442 |
| Mar 25, 25 | Pinto Daniel E | other | 22,688 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VYLD coverage
Recent articles, reports, and earnings notes.
No research on VYLD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VYLD report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.